Gene: CCND1
Official Full Name: cyclin D1provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the highly conserved cyclin family, whose members are characterized by a dramatic periodicity in protein abundance throughout the cell cycle. Cyclins function as regulators of CDK kinases. Different cyclins exhibit distinct expression and degradation patterns which contribute to the temporal coordination of each mitotic event. This cyclin forms a complex with and functions as a regulatory subunit of CDK4 or CDK6, whose activity is required for cell cycle G1/S transition. This protein has been shown to interact with tumor suppressor protein Rb and the expression of this gene is regulated positively by Rb. Mutations, amplification and overexpression of this gene, which alters cell cycle progression, are observed frequently in a variety of human cancers. [provided by RefSeq, Dec 2019]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO00236 | CCND1 Knockout cell line (HEK293) | Human | CCND1 | 1:3~1:6 | Negative | Online Inquiry |
KO10101 | CCND1 Knockout cell line (HeLa) | Human | CCND1 | 1:3~1:6 | Negative | Online Inquiry |
KO10102 | CCND1 Knockout cell line (HCT 116) | Human | CCND1 | 1:2~1:4 | Negative | Online Inquiry |
KO10103 | CCND1 Knockout cell line (A549) | Human | CCND1 | 1:3~1:4 | Negative | Online Inquiry |
CCND1 Gene Knockout Cell Lines are specialized cellular models designed to study the functional role of the CCND1 gene, which encodes cyclin D1, a key regulator of the cell cycle. These knockout cell lines have been genetically engineered to disrupt the CCND1 gene, resulting in the loss of cyclin D1 expression. This targeted modification allows researchers to examine the downstream effects of cyclin D1 absence on cellular processes, including proliferation, differentiation, and apoptosis.
The primary mechanism of action revolves around the regulation of the G1 phase of the cell cycle, where cyclin D1 partners with cyclin-dependent kinases to facilitate the transition from the resting phase to DNA synthesis. By employing CCND1 Gene Knockout Cell Lines, scientists can create a controlled environment to explore cyclin D1's role in oncogenesis, particularly in cancers where its dysregulation is implicated.
From a scientific standpoint, these cell lines are invaluable in both research and clinical settings. They can help elucidate the molecular pathways affected by cyclin D1, paving the way for therapeutic interventions targeting related pathways in cancer treatment. Furthermore, these knockout models offer robust systems for drug discovery, aiding in the identification of compounds that could effectively target cyclin D1-related malignancies.
One of the specific advantages of using CCND1 Gene Knockout Cell Lines is their ability to provide high specificity and reproducibility in experimental results, which are often challenging to achieve with conventional methods or less targeted cell lines. Additionally, their use can reduce the variability commonly encountered with primary cells, leading to more consistent data.
For researchers and clinicians alike, the real value of these cell lines lies in their potential to drive advancements in cancer research and treatment strategies. They enable comprehensive studies that can lead to novel therapeutic approaches, enhancing the understanding of cancer biology.
At our company, we pride ourselves on delivering high-quality biological products that empower the research community. Our expertise in genetic engineering and cell line development ensures that our CCND1 Gene Knockout Cell Lines embody precision, reliability, and applicability across various scientific endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.